Extra Super Avana: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
| Product dosage: 260mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $7.25 | $261.07 (0%) | 🛒 Add to cart |
| 60 | $7.03 | $435.12 $421.73 (3%) | 🛒 Add to cart |
| 88 | $6.93
Best per pill | $638.18 $609.50 (4%) | 🛒 Add to cart |
Extra Super Avana is a prescription medication specifically formulated to address two of the most common male sexual health concerns: erectile dysfunction and premature ejaculation. Combining the proven efficacy of avanafil for robust, reliable erections with the ejaculatory control benefits of dapoxetine, this dual-component treatment offers a comprehensive solution for men seeking to improve their sexual performance and confidence. By targeting both physiological and psychological aspects of sexual dysfunction, Extra Super Avana provides a synergistic approach that enhances overall sexual satisfaction for both partners. It is designed for adult men who experience these concurrent conditions and seek a fast-acting, effective treatment option under appropriate medical supervision.
Features
- Contains two active ingredients: Avanafil (100mg) and Dapoxetine (60mg)
- Rapid onset of action, with avanafil taking effect in as little as 15-30 minutes
- Dapoxetine component specifically targets serotonin receptors to delay ejaculation
- High selectivity for phosphodiesterase type 5 (PDE5) inhibition
- Developed through advanced pharmaceutical compounding techniques
- Manufactured under strict quality control standards
- Presented in convenient tablet form for oral administration
Benefits
- Achieves and maintains firm erections sufficient for sexual activity
- Significantly increases intravaginal ejaculatory latency time
- Enhances sexual confidence and reduces performance anxiety
- Improves overall sexual satisfaction for both partners
- Allows for more spontaneous sexual activity due to rapid onset
- Provides comprehensive treatment for dual sexual dysfunction concerns
Common use
Extra Super Avana is primarily prescribed for the treatment of erectile dysfunction (ED) in combination with premature ejaculation (PE) in adult men. It is indicated for patients who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual performance, concurrently with the inability to control ejaculation during sexual activity. The medication is designed for use prior to anticipated sexual activity rather than as a daily regimen. Healthcare providers may recommend this treatment for patients who have not achieved satisfactory results with single-component therapies or who present with both conditions simultaneously. It is typically prescribed after a thorough medical evaluation to rule out underlying conditions that might contribute to sexual dysfunction.
Dosage and direction
The recommended dosage is one tablet taken approximately 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a glass of water and may be taken with or without food, though high-fat meals may delay the onset of action. Do not exceed one tablet within a 24-hour period. The medication should only be used when sexual activity is anticipated rather than on a daily basis. Patients should follow their healthcare provider’s specific instructions regarding dosage, as adjustments may be necessary based on individual response and tolerance. The timing of administration may be adjusted based on individual response, with some patients finding optimal results with intake 15-45 minutes before sexual activity.
Precautions
Patients should undergo a thorough medical evaluation before beginning treatment with Extra Super Avana to assess cardiovascular health and rule out contraindications. Those with cardiovascular risk factors may require stress testing before prescription. Use caution when rising from a sitting or lying position due to potential blood pressure changes. Alcohol consumption should be limited as it may increase the risk of adverse effects including dizziness and orthostatic hypotension. The medication contains dapoxetine, which may cause dizziness or syncope; patients should avoid hazardous activities until they understand how the medication affects them. Regular follow-up with a healthcare provider is recommended to monitor treatment efficacy and safety. Patients should inform their physician of all medications they are taking to avoid potential interactions.
Contraindications
Extra Super Avana is contraindicated in patients taking nitrates in any form, including nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate, due to the risk of potentially fatal hypotension. It is also contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. Patients with severe hepatic impairment should not use this medication. Those with a history of hypersensitivity to avanafil, dapoxetine, or any component of the formulation should avoid this treatment. The medication is contraindicated in patients with significant cardiovascular disease where sexual activity is not advised, including unstable angina, recent myocardial infarction, or life-threatening arrhythmias. Patients with hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication.
Possible side effects
Common side effects may include headache, dizziness, flushing, nasal congestion, nausea, diarrhea, and insomnia. These effects are typically mild to moderate and transient. Less frequently, patients may experience visual disturbances, palpitations, increased blood pressure, or orthostatic hypotension. Some patients report dry mouth, anxiety, or fatigue. Serious but rare side effects include priapism (prolonged and painful erection lasting more than 4 hours), sudden hearing loss, sudden vision loss, or syncope. Allergic reactions, though uncommon, may present as rash, itching, or difficulty breathing. Patients should seek immediate medical attention for any severe or persistent side effects, particularly chest pain, irregular heartbeat, or seizures.
Drug interaction
Extra Super Avana has significant interaction potential with numerous medications. Concomitant use with nitrates is absolutely contraindicated. Strong CYP3A4 inhibitors such as ketoconazole, ritonavir, and clarithromycin may significantly increase avanafil exposure. Moderate CYP3A4 inhibitors like erythromycin and fluconazole may also increase levels. Concurrent use with alpha-blockers may potentiate blood pressure-lowering effects. Dapoxetine interacts with serotonergic drugs including SSRIs, SNRIs, tricyclic antidepressants, and triptans, increasing serotonin syndrome risk. Medications that prolong QT interval should be used cautiously. HIV protease inhibitors, some antifungal agents, and certain antibiotics may affect drug metabolism. Patients should provide their healthcare provider with a complete list of all prescription and non-prescription medications, including herbal supplements.
Missed dose
As Extra Super Avana is taken on an as-needed basis rather than a scheduled regimen, the concept of a “missed dose” does not typically apply. Patients should take one tablet approximately 30 minutes before anticipated sexual activity when needed. If a patient forgets to take the medication before sexual activity, they should not take a double dose later. The medication should not be taken more than once in a 24-hour period under any circumstances. If sexual activity occurs more than once within 24 hours, patients should wait until at least 24 hours have passed since the previous dose before taking another tablet.
Overdose
In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include severe headache, dizziness, nausea, vomiting, palpitations, chest pain, prolonged erection, fainting, or seizures. Management is primarily supportive and symptomatic. Cardiovascular status should be monitored closely. Priapism requires immediate medical intervention to prevent permanent tissue damage. Hemodialysis is not expected to significantly enhance elimination of either active component due to high protein binding. Patients should be advised to store medication properly and never exceed the prescribed dosage.
Storage
Store Extra Super Avana at room temperature between 15-30°C (59-86°F) in the original container. Protect from light and moisture. Keep the container tightly closed when not in use. Do not store in bathrooms or other areas with high humidity. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused or expired medication according to local regulations or through medication take-back programs. Do not flush medications down the toilet or pour down a drain unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Extra Super Avana is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Patients should consult with their healthcare provider for proper diagnosis and treatment recommendations. The information provided here is not exhaustive and should not replace professional medical guidance. Never initiate, discontinue, or change dosage of any medication without consulting your healthcare provider.
Reviews
Clinical studies demonstrate that Extra Super Avana significantly improves erectile function and ejaculatory control compared to placebo. In randomized controlled trials, patients reported improved sexual satisfaction and relationship quality. Many users report increased confidence and reduced anxiety related to sexual performance. Some patients note the convenience of addressing both conditions with a single medication. Effectiveness may vary based on individual factors including overall health, psychological state, and relationship dynamics. Most adverse effects are reported as mild and transient. Long-term satisfaction rates remain high among appropriate candidates who follow medical guidance and maintain realistic expectations regarding treatment outcomes.